RECURSION PHARMACEUTICALS IN shareholders Q1 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 158 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.9%.

RECURSION PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
GoalFusion Wealth Management, LLC 20,000$133,4000.10%
DARK FOREST CAPITAL MANAGEMENT LP 52,267$348,6210.08%
XTX Topco Ltd 48,138$321,0800.07%
Bridgefront Capital, LLC 14,610$97,4490.06%
TITLEIST ASSET MANAGEMENT, LLC 35,750$238,4530.05%
Dynamic Technology Lab Private Ltd 72,238$4820.04%
AXQ CAPITAL, LP 15,374$102,5450.04%
Virtus ETF Advisers LLC 11,085$73,9370.04%
Nikko Asset Management Americas, Inc. 501,977$3,297,9890.04%
Trexquant Investment LP 200,366$1,336,4410.04%
FOX RUN MANAGEMENT, L.L.C. 16,734$111,6160.04%
Jump Financial, LLC 129,541$864,0380.04%
PROFUND ADVISORS LLC 71,224$475,0640.03%
Pentwater Capital Management LP 420,000$2,801,4000.03%
Manchester Capital Management LLC 26,880$179,2900.02%
Bayesian Capital Management, LP 24,095$160,7140.02%
Rafferty Asset Management, LLC 449,982$3,001,3800.02%
OCCUDO QUANTITATIVE STRATEGIES LP 31,977$213,2870.02%
Cubist Systematic Strategies, LLC 406,662$2,712,4350.02%
Accel Wealth Management 6,100$40,6870.02%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q1 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.